Initial results confirm more positive screening results, diagnostic procedures, cancer ID'd with CT versus standard chest X-rays.
Pioneering biophotonics technology is the first screening method to detect the early presence of ovarian cancer in humans
Integrated 2-dimensional (2D) and 3-dimensional (3D) mammography improves the detection of breast cancer and reduces false-positive findings.
Computer-aided detection helped find more cases of noninvasive breast cancer, but also led to more unnecessary testing in the absence of disease.
Older adults undergo cancer screening even when unlikely to benefit and when at risk of harm, but stopping screening is not discussed.
A new diagnostic test that uses the technique of metabolomic analysis may be a safe and easy screening method that could improve the prognosis of patients with pancreatic cancer through earlier detection.
Women 50 to 74 who have mammography every 2 years have similar risk of advanced disease as, and fewer false-positives than, annual screeners.
A recent study uncovered adenoma detection rates significantly higher than those set in national guidelines.
Clinicians should recommend annual lung cancer screening with low-dose CT for certain high-risk patients, according to new American Cancer Society screening guidelines.
Cancer mortality has fallen 20% since its peak in 1991, according to the latest annual report from the American Cancer Society.
A set of proteins circulating in blood may flag the presence of lymphedema, which is difficult to diagnose before the onset of physical symptoms.
The American Society of Clinical Oncology has released a nearly 100-page report detailing the year's most significant developments in cancer.
Adding three-dimensional breast imaging to standard digital mammography increases diagnostic accuracy and reduces false-positive recall rates.
Black women have the highest death rate from breast cancer of all racial and ethnic groups, and are 40% more likely to die of the disease than are white women, according to a new report from the CDC.
It may be reasonable to use methods other than colonoscopy to rescreen people who had negative results on their first screening colonoscopy.
For ovarian cancer and perhaps other cancer types, cell stiffness may be a useful biomarker to measure relative metastatic potential.
Assessing how water moves through breast tissue may reduce false-positive findings among women undergoing dynamic contrast-enhanced MRI.
A simple three-question survey has been developed to help clinicians identify women who may be experiencing symptoms of ovarian cancer.
The use of colonoscopy to screen for colorectal cancer may explain the significant decrease in the incidence of that cancer over the past decade. While colonoscopy is now the most common colorectal cancer screening method, evidence has conflicted about how its effectiveness compares with sigmoidoscopy.
Two of three main recommendations for colonoscopy surveillance are now supported by stronger evidence than they were in 2006.
The somo-V Automated Breast Ultrasound System received FDA approval for use in combination with standard mammography in women with dense breast tissue.
Dividing bowel preparation solution into two doses resulted in better preparation quality, detection rates, and colonoscopy completion rates.
The immune systems of transplant recipients and lymphoma patients tend to be significantly depressed, making these patients more susceptible to melanoma, according to a review on the role of immunosuppression in melanoma.
An analysis of breath samples from patients with pulmonary nodules distinguished benign from malignant growths in a recent study.
The mailing of fecal occult blood test (FOBT) kits boosted colorectal cancer screening rates in a low-income, racially diverse patient population.
Characteristics of the colonoscopy rather than those of the adenomas removed may be the most significant determinants of colorectal cancer risk.
A lung cancer risk-prediction model effectively identified individuals who would benefit most from low-dose computed tomography (CT) screening.
Overall survival rates have improved for men with prostate cancer following the introduction of PSA screening, particularly for African Americans.
News about pertuzumab injection (Perjeta); ondansetron (Zofran); carfilzomib (Kyprolis); Therascreen KRAS RGQ PCR Kit; Prostate Health Index (phi); and Prepopik
HIV-positive women with normal Pap results and no oncogenic HPV do not appear to be at greater risk of cervical CA than HIV-negative women.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|